Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

Overview of attention for article published in Journal of Hepatology, December 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 17 X users

bluesky: 1 Bluesky user

Readers on

mendeley: 73 Mendeley

So far, Altmetric has seen 19 X posts from 17 X users, with an upper bound of 14,211 followers.

Profundizando en la respuesta a la inmunoterapia contra el cáncer de hígado https://t.co/qselSrXfUt Más información: Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma …

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma https://t.co/WiLeHDCS2G #hvhebron #hepato [Text complet]

RT @CappuynsSarah: ‼️Our latest publication in @JHepatology ‼️ ✅Response to atezo+bev in HCC is immune- vs angiogenesis-driven. ⛔️Resistan…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 15 additional X posts.